Kenya — national schedule (2025): which vaccines and when

• At birthBCG (tuberculosis) · Polio, oral (OPV)
• 6 weeksDTwP-Hib-HepB (pentavalent) · Polio, oral (OPV) · Pneumococcal conjugate, 10-valent · Rotavirus, 2-dose course
• 10 weeksDTwP-Hib-HepB (pentavalent) · Polio, oral (OPV) · Pneumococcal conjugate, 10-valent · Rotavirus, 2-dose course
• 14 weeksDTwP-Hib-HepB (pentavalent) · Polio, inactivated (IPV) · Polio, oral (OPV) · Pneumococcal conjugate, 10-valent · Rotavirus, 2-dose course
• 6 monthsMalaria (RTS,S / R21) (some regions only) · Vitamin A (a supplement, not a vaccine)
• 7 monthsMalaria (RTS,S / R21) (some regions only)
• 9 monthsPolio, inactivated (IPV) · Malaria (RTS,S / R21) (some regions only) · MR (measles, rubella) · Typhoid, conjugate
• 12 monthsVitamin A (a supplement, not a vaccine)
• 18 monthsMR (measles, rubella) · Vitamin A (a supplement, not a vaccine)
• 2 yearsMalaria (RTS,S / R21) (some regions only) · Vitamin A (a supplement, not a vaccine)
• 30 monthsVitamin A (a supplement, not a vaccine)
• 3 yearsVitamin A (a supplement, not a vaccine)
• 10 yearsHPV, 4-valent (girls) — 2nd dose 6 months later

This is the schedule Kenya reports to WHO, published as data under WHO's open licence — not a copy of the ministry's own page. The ministry can change a date without WHO's file changing the same week, so if your health centre says something different, your health centre is right. Two products on one line are alternatives for a single injection, not two. One of these vaccines is not given everywhere in the country, only in some regions; the line says so. What the source records about it: «Malaria (RTS,S / R21) — Offered in 8 counties with prevalence of malaria- Kisumu, Homabay, Siaya, Migori, Vihiga, Kakamega, Busia, Bungoma to the Surviving infants, (both male and female) meeting the age of administration».

WHO/UNICEF — national immunization schedule as reported by Kenya to WHO; WIISE public dataset AD_SCHEDULES, 2025 reporting year (checked on September 18, 2026) · official page